Abstract
The European peripheral vascular (PV) device market, comprising France,
Germany, Italy, and the UK, will undergo steady revenue growth through 2013.
Patient volume expansion will be driven by the increasing over - 65 cohort in
the region and the rising prevalence of peripheral vascular disease (PVD),
diabetes, and end - stage renal disease.
| 
View Cart
